Catalyst Wire Dossier Catalyst Wire Dossier

MK-5592 (Posaconazole)

posaconazole · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-5592 (Posaconazole), covering 2019-01-11 to 2019-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) [Phase 3]

See pricing